Literature DB >> 4577014

A double blind trial for the clinical management of psychogenic headache.

A Okasha, H A Ghaleb, A Sadek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4577014     DOI： 10.1192/bjp.122.2.181

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  10 in total

Review 1.  Antidepressants as analgesics: a review of randomized controlled trials.

Authors:  M E Lynch
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

2.  [Not Available].

Authors:  R Wörz
Journal:  Schmerz       Date:  1992-03       Impact factor: 1.107

3.  [Not Available].

Authors:  A Willweber-Strumpf; M Zenz
Journal:  Schmerz       Date:  1989-09       Impact factor: 1.107

Review 4.  The use of antidepressants in the treatment of chronic pain. A review of the current evidence.

Authors:  G Magni
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 5.  Minor tranquillizers in somatic disorders.

Authors:  C Krogh; W M McLean; Y D LaPierre
Journal:  Can Med Assoc J       Date:  1978-05-06       Impact factor: 8.262

Review 6.  Tricyclic antidepressants and headaches: systematic review and meta-analysis.

Authors:  Jeffrey L Jackson; William Shimeall; Laura Sessums; Kent J Dezee; Dorothy Becher; Margretta Diemer; Elizabeth Berbano; Patrick G O'Malley
Journal:  BMJ       Date:  2010-10-20

Review 7.  Low dosage tricyclic antidepressants for depression.

Authors:  T Furukawa; H McGuire; C Barbui
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 8.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  [Treatment of chronic pain syndromes with antidepressants.].

Authors:  R Wörz; J Berlin
Journal:  Schmerz       Date:  1989-03       Impact factor: 1.107

10.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.